Marvin Rubenstein

1.1k total citations
113 papers, 847 citations indexed

About

Marvin Rubenstein is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marvin Rubenstein has authored 113 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 38 papers in Pulmonary and Respiratory Medicine and 28 papers in Oncology. Recurrent topics in Marvin Rubenstein's work include Prostate Cancer Treatment and Research (30 papers), RNA Interference and Gene Delivery (21 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Marvin Rubenstein is often cited by papers focused on Prostate Cancer Treatment and Research (30 papers), RNA Interference and Gene Delivery (21 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Marvin Rubenstein collaborates with scholars based in United States and Israel. Marvin Rubenstein's co-authors include Patrick Guinan, Yelena Mirochnik, Michael W. Shaw, K.M. Anderson, Courtney M.P. Hollowell, Charles F. McKiel, Paul S. Ray, Pauline M. Chou, K.M. Anderson and Paul V. Targonski and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Marvin Rubenstein

110 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marvin Rubenstein United States 16 488 295 196 176 107 113 847
Yun Oh United States 18 561 1.1× 310 1.1× 373 1.9× 137 0.8× 49 0.5× 28 1.0k
D. Fan United States 14 404 0.8× 168 0.6× 359 1.8× 119 0.7× 64 0.6× 23 804
S. Streit Germany 7 481 1.0× 138 0.5× 364 1.9× 130 0.7× 47 0.4× 8 823
Timothy McDonnell United States 12 343 0.7× 157 0.5× 406 2.1× 219 1.2× 38 0.4× 19 866
David Molkentine United States 16 371 0.8× 186 0.6× 357 1.8× 125 0.7× 60 0.6× 30 708
Sujatha Jagadeeswaran United States 12 465 1.0× 169 0.6× 360 1.8× 197 1.1× 74 0.7× 16 973
Mariko Mihara Japan 21 745 1.5× 203 0.7× 674 3.4× 230 1.3× 125 1.2× 38 1.3k
Lakshmeswari Ravi United States 11 531 1.1× 136 0.5× 280 1.4× 219 1.2× 99 0.9× 14 866
Dineli Wickramasinghe United States 17 953 2.0× 312 1.1× 359 1.8× 161 0.9× 107 1.0× 24 1.6k
Alexandra Eyzaguirre United States 8 722 1.5× 244 0.8× 564 2.9× 263 1.5× 56 0.5× 13 1.1k

Countries citing papers authored by Marvin Rubenstein

Since Specialization
Citations

This map shows the geographic impact of Marvin Rubenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marvin Rubenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marvin Rubenstein more than expected).

Fields of papers citing papers by Marvin Rubenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marvin Rubenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marvin Rubenstein. The network helps show where Marvin Rubenstein may publish in the future.

Co-authorship network of co-authors of Marvin Rubenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Marvin Rubenstein. A scholar is included among the top collaborators of Marvin Rubenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marvin Rubenstein. Marvin Rubenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rubenstein, Marvin, Courtney M.P. Hollowell, & Patrick Guinan. (2015). Following Inhibition of BCL-2 by Antisense Oligonucleotides Compensatory Suppression of Apoptosis Involves the Direct Signal Transduction Pathway of LNCaP Cells. 4(1). 1–10. 2 indexed citations
3.
Anderson, K.M., Patrick Guinan, & Marvin Rubenstein. (2013). Normoxic or hypoxic CD44/CD41 a 2 B 1 integrin-positive prostate PC3 cell side fractions and cancer stem cells. Medical Oncology. 31(1). 779–779. 4 indexed citations
4.
Anderson, K.M., et al.. (2009). In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.. PubMed. 29(11). 4579–88. 32 indexed citations
5.
Rubenstein, Marvin, Courtney M.P. Hollowell, & Patrick Guinan. (2009). Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR. Medical Oncology. 27(4). 1212–1218. 7 indexed citations
6.
7.
Rubenstein, Marvin, et al.. (2005). Reactive oxygen species and redox-induced programmed cell death due to MK 886: cells ("soil") "trump" agent ("seed").. PubMed. 19(1). 109–18. 3 indexed citations
8.
Rubenstein, Marvin, et al.. (2005). Correlation Between PSMA and VEGF Expression as Markers for LNCaP Tumor Angiogenesis. BioMed Research International. 2005(3). 287–290. 23 indexed citations
9.
Anderson, K.M., et al.. (2004). Acute changes in U937 nuclear Ca2+ preceding type 1 "apoptotic" programmed cell death due to MK 886.. PubMed. 24(5A). 2601–15. 5 indexed citations
10.
11.
Rubenstein, Marvin, et al.. (2002). Backbone modification alters the efficacy of antisenseoligonucleotides directed against mRNA encoding either TGF-alpha orEGFR in the treatment of prostate cancer cell lines. Methods and Findings in Experimental and Clinical Pharmacology. 24(10). 649–649. 4 indexed citations
12.
Rubenstein, Marvin, et al.. (1999). In vivo establishment of T98G human gliobastoma. Methods and Findings in Experimental and Clinical Pharmacology. 21(6). 391–391. 24 indexed citations
13.
Rubenstein, Marvin, et al.. (1995). Orthotopic placement of the dunning R3327 AT‐3 prostate tumor in the copenhagen X fischer rat. The Prostate. 27(3). 148–153. 5 indexed citations
14.
Guinan, Patrick, et al.. (1995). Renal cell carcinoma: Comparison of the tnm and robson stage groupings. Journal of Surgical Oncology. 59(3). 186–189. 25 indexed citations
15.
Rubenstein, Marvin, et al.. (1993). Differential effect of xanthopterin and biopterin on cell growth. International Journal of Biochemistry. 25(12). 1873–1880. 2 indexed citations
16.
Ray, Paul S., et al.. (1993). Renal cell carcinoma: The size variable. Journal of Surgical Oncology. 54(3). 163–166. 13 indexed citations
17.
Shaw, Michael W., Charles F. McKiel, Vera Ray, Marvin Rubenstein, & Patrick Guinan. (1991). Characterization of cellular infiltrates in the rat urinary bladder following BCG and thiotepa intravesical therapy. Journal of Surgical Oncology. 46(1). 48–52. 2 indexed citations
18.
Chou, P.M., V. Ray, Michael W. Shaw, Marvin Rubenstein, & Patrick Guinan. (1990). An immunohistologic characterization of human prostatic atypical hyperplasia. Urological Research. 18(3). 193–196. 3 indexed citations
19.
Guinan, Patrick, Michael W. Shaw, Paul V. Targonski, V. Ray, & Marvin Rubenstein. (1989). Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue. Journal of Surgical Oncology. 42(3). 175–180. 11 indexed citations
20.
Rubenstein, Marvin, Michael W. Shaw, Alvin Dubin, Charles F. McKiel, & Patrick Guinan. (1988). Effect of Bcg Upon Functional and Phenotypic Immune Markers in Rats Bearing the Dunning R3327 Mat-Lylu Prostatic Adenocarcinoma. Immunopharmacology and Immunotoxicology. 10(4). 579–596. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun Oh Breakdown of academic impact, for papers by D. Fan Breakdown of academic impact, for papers by S. Streit Breakdown of academic impact, for papers by Timothy McDonnell Breakdown of academic impact, for papers by David Molkentine Breakdown of academic impact, for papers by Sujatha Jagadeeswaran Breakdown of academic impact, for papers by Mariko Mihara Breakdown of academic impact, for papers by Lakshmeswari Ravi Breakdown of academic impact, for papers by Dineli Wickramasinghe Breakdown of academic impact, for papers by Alexandra Eyzaguirre
Rankless by CCL
2026